Let’s feel better together! Visit our cabinet regularly to find an ever-growing stock of health news you can use; stories of hope and healing; and resources to help you finesse your approach to self-care and preventative health.
Let’s feel better together! Visit our cabinet regularly to find: an ever-growing stock of health news you can use; stories of hope and healing; and resources to help you finesse your approach to self-care and preventative health.
Smoking and vaping addiction are major public health issues, affecting millions worldwide. Despite the known health risks, many struggle to quit due to powerful nicotine cravings. While traditional methods like nicotine replacement therapy and counseling work for some, new treatments are being explored. One promising option is GLP-1 medications.
GLP-1 receptor agonists (GLP-1s), commonly used to manage type 2 diabetes and support weight loss, have shown potential in reducing nicotine cravings. We'll explore how GLP-1s can aid smoking and vaping cessation, helping individuals take control of their addiction and improve their health.
Smoking and vaping addiction are major public health issues, affecting millions worldwide. Despite the known health risks, many struggle to quit due to powerful nicotine cravings. While traditional methods like nicotine replacement therapy and counseling work for some, new treatments are being explored. One promising option is GLP-1 medications.
GLP-1 receptor agonists (GLP-1s), commonly used to manage type 2 diabetes and support weight loss, have shown potential in reducing nicotine cravings. We'll explore how GLP-1s can aid smoking and vaping cessation, helping individuals take control of their addiction and improve their health.
Rume Health is the Management Service Organization for
Rume Medical Group, Inc, a network of healthcare providers.
